Singapore markets open in 1 hour 3 minutes

CHRS Aug 2022 12.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.1000+0.6300 (+134.04%)
As of 12:52PM EDT. Market open.
Full screen
Previous close0.4700
Open1.1000
Bid0.6000
Ask1.5000
Strike12.50
Expiry date2022-08-19
Day's range1.1000 - 1.1000
Contract rangeN/A
Volume1
Open interest3.96k
  • Motley Fool

    Coherus BioSciences (CHRS) Q2 2022 Earnings Call Transcript

    This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K. Today's call includes forward-looking statements regarding Coherus' current expectations about future events. All these forward-looking statements involve substantial risks and uncertainties that are beyond our control and could cause actual results, performance or achievements to differ from results, performance or achievements implied by the forward-looking statements.

  • Zacks

    Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates

    Coherus BioSciences (CHRS) delivered earnings and revenue surprises of 32.29% and 3.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Wall Street Analysts Predict an 85% Upside in Coherus BioSciences (CHRS): Here's What You Should Know

    The consensus price target hints at an 84.6% upside potential for Coherus BioSciences (CHRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.